Exome Asset Management
Wongmo Kang is a Senior Investment Analyst at Exome Asset Management with previous experience at Deloitte as a Consultant in Financial Risk, Transaction & Restructuring. Prior to that, Wongmo served as a Senior KATUSA at the US Army and worked as an M&A Research Assistant at Mercer. Wongmo also has experience as an Assistant Secretary at The National Assembly of The Republic of Korea. Wongmo holds an MBA from Columbia Business School and a BS/MS in Finance and Accounting from NYU Stern School of Business.
This person is not in any teams
Exome Asset Management
Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare.